-
Company Profile
NewChiasma Inc – Company Profile
Chiasma Inc (Chiasma) is a clinical-stage bio pharmaceutical company. The company involves in development of oral medications for the treatment of rare and serious chronic diseases. It develops oral medications through its transient permeability enhancer (TPE) technology platform, which is designed to enable the development of oral forms of therapies. It clinical product candidate includes oral octreotide capsules, a novel formulation of octreotide which is in Phase 3 clinical trials intended for the treatment of adult patients with acromegaly. The...
Add to Basket -
Product Insights
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Acromegaly is a hormonal disorder that develops when the pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth, and sleep apnea. Treatment includes surgery, dopamine agonists, and growth hormone antagonists. The Acromegaly pipeline market research report provides comprehensive information on the therapeutics under development for Acromegaly, complete with analysis by stage of development, drug target, mechanism of action...
-
Sector Analysis
Contract Manufacturing Service Agreements – Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion
This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMO's performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry.
-
Product Insights
Portal Hypertension Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2018" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Portal Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Portal Hypertension Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Portal Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Portal Hypertension Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Portal Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...